[Secondary hyperaldosteronism of ascitogenic cirrhosis. Therapeutic results].
D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology*; D008103:Liver Cirrhosis / Q000150:complications*; D011241:Prednisone / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use*
D013148:Spironolactone; D011241:Prednisone
L'hyperaldostéronisme secondaire des cirrhoses ascitogènes. Conséquences thérapeutiques.